Novo Nordisk CEO Remains Open to Bolt-On Acquisitions, But Rules out Transformative Deals

Chief Executive Mike Doustdar’s comments come amid sector focus on M&A and after Novo Nordisk made two disclosures in recent days on its future pipeline that disappointed investors.